KR950700322A - 이소스테릭 항헤르페스 펩타이드 유도체(Isosteric antiherpes peptide derivatives) - Google Patents

이소스테릭 항헤르페스 펩타이드 유도체(Isosteric antiherpes peptide derivatives)

Info

Publication number
KR950700322A
KR950700322A KR1019940703166A KR19940703166A KR950700322A KR 950700322 A KR950700322 A KR 950700322A KR 1019940703166 A KR1019940703166 A KR 1019940703166A KR 19940703166 A KR19940703166 A KR 19940703166A KR 950700322 A KR950700322 A KR 950700322A
Authority
KR
South Korea
Prior art keywords
alkyl
amino acid
peptide derivatives
isosteric
nhch
Prior art date
Application number
KR1019940703166A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700322A publication Critical patent/KR950700322A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019940703166A 1992-03-12 1994-09-10 이소스테릭 항헤르페스 펩타이드 유도체(Isosteric antiherpes peptide derivatives) KR950700322A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84991892A 1992-03-12 1992-03-12
PCT/CA1993/000095 WO1993018056A1 (en) 1992-03-12 1993-03-12 Isosteric antiherpes peptide derivatives

Publications (1)

Publication Number Publication Date
KR950700322A true KR950700322A (ko) 1995-01-16

Family

ID=25306833

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940703166A KR950700322A (ko) 1992-03-12 1994-09-10 이소스테릭 항헤르페스 펩타이드 유도체(Isosteric antiherpes peptide derivatives)

Country Status (24)

Country Link
EP (1) EP0560267B1 (ko)
JP (1) JPH0625131A (ko)
KR (1) KR950700322A (ko)
AT (1) ATE169931T1 (ko)
BR (1) BR9306074A (ko)
CA (1) CA2131186C (ko)
CZ (1) CZ220994A3 (ko)
DE (1) DE69320390T2 (ko)
EE (1) EE9400312A (ko)
FI (1) FI944187A0 (ko)
HU (2) HUT68675A (ko)
IL (1) IL105001A0 (ko)
LT (1) LT3270B (ko)
LV (1) LV10461B (ko)
MX (1) MX9301343A (ko)
NO (1) NO943345D0 (ko)
NZ (1) NZ251266A (ko)
PH (1) PH30453A (ko)
RU (1) RU94040865A (ko)
SG (1) SG42995A1 (ko)
SK (1) SK107794A3 (ko)
TW (1) TW278080B (ko)
WO (1) WO1993018056A1 (ko)
ZA (1) ZA931745B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139169C (en) * 1994-12-28 2001-05-01 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
CA2095408A1 (en) * 1993-05-03 1994-11-04 James Gus Chafouleas Method of combating acyclovir-resistant herpes simplex viral infections
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
DE69943314D1 (de) * 1998-02-12 2011-05-12 Kapil N Bhalla Sphingolipid-derivate und verfahren zu deren verwendung
RU2555357C2 (ru) * 2008-04-08 2015-07-10 Мерк Патент Гмбх Композиции, содержащие циклические пептиды, и способы их применения
CN112996789A (zh) 2018-09-12 2021-06-18 诺华股份有限公司 抗病毒吡啶并吡嗪二酮化合物
KR20220070005A (ko) 2019-09-26 2022-05-27 노파르티스 아게 항바이러스성 피라졸로피리디논 화합물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US481432A (en) 1892-08-23 soler
US4795740A (en) 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4845195A (en) 1987-05-22 1989-07-04 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
US4837304A (en) 1987-05-22 1989-06-06 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
CA1340684C (en) 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides
ATE118785T1 (de) 1989-07-07 1995-03-15 Bio Mega Boehringer Ingelheim Pentapeptidderivate, wirksam gegen herpes, die eine ersetzte asparaginsäureseitenkette enthalten.
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
ATE123294T1 (de) * 1989-07-07 1995-06-15 Bio Mega Boehringer Ingelheim Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure.
US5110799A (en) 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
CA2018801C (en) 1990-06-12 2000-08-22 Pierre Louis Beaulieu Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections

Also Published As

Publication number Publication date
RU94040865A (ru) 1996-08-10
HUT68675A (en) 1995-07-28
NZ251266A (en) 1996-08-27
TW278080B (ko) 1996-06-11
HU211926A9 (en) 1996-01-29
SG42995A1 (en) 1997-10-17
FI944187A (fi) 1994-09-12
AU671825B2 (en) 1996-09-12
JPH0625131A (ja) 1994-02-01
MX9301343A (es) 1994-01-31
DE69320390T2 (de) 1999-02-11
PH30453A (en) 1997-05-28
ATE169931T1 (de) 1998-09-15
CA2131186A1 (en) 1993-09-16
CA2131186C (en) 2000-12-12
EP0560267A1 (en) 1993-09-15
LV10461B (en) 1996-02-20
WO1993018056A1 (en) 1993-09-16
IL105001A0 (en) 1993-07-08
NO943345L (no) 1994-09-09
AU3880793A (en) 1993-10-05
DE69320390D1 (de) 1998-09-24
FI944187A0 (fi) 1994-09-12
EP0560267B1 (en) 1998-08-19
EE9400312A (et) 1996-04-15
LT3270B (en) 1995-05-25
CZ220994A3 (en) 1995-09-13
SK107794A3 (en) 1995-03-08
NO943345D0 (no) 1994-09-09
ZA931745B (en) 1993-09-24
LV10461A (lv) 1995-02-20
LTIP408A (en) 1994-09-25
HU9402593D0 (en) 1994-11-28
BR9306074A (pt) 1997-11-18

Similar Documents

Publication Publication Date Title
KR950700322A (ko) 이소스테릭 항헤르페스 펩타이드 유도체(Isosteric antiherpes peptide derivatives)
ES2152269T3 (es) Inhibidores de ribonucleotido-reductasa de herpesvirus.
DE69023977D1 (de) Antivirale Peptide, die eine 2-Ketoalkylaminosäureseitenkette enthalten.
IL94980A0 (en) Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain,their preparation and pharmaceutical compositions containing them
ATE167682T1 (de) Peptidderivate mit einem ureido-n-terminus gegen herpes
CA2019005A1 (en) Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid